Genetic polymorphisms and their correlation with dyslipidemia in Chinese patients diagnosed with diabetes mellitus

Table 4 Association between genetic polymorphisms and dyslipidemia

Gene	Polymorphism	Genetic model	Genotype	OR (95%CI)	P value
APOE	rs7412	Codominant	C/C, C/T, T/T	1.00 (reference), 1.28 (0.92-1.79), 2.81 (1.12-7.04)	0.036
APOE	rs7412	Dominant	C/C, C/T + T/T	1.00 (reference), 1.41 (1.03-1.93)	0.031
APOE	rs429358	Codominant	T/T, T/C, C/C	1.00 (reference), 1.19 (0.95-1.49), 2.14 (1.38-3.32)	0.001
APOE	rs429358	Dominant	T/T, T/C + C/C	1.00 (reference), 1.36 (1.11-1.67)	0.003
LPL	rs328	Codominant	C/C, C/G, G/G	1.00 (reference), 1.23 (0.99-1.53), 2.05 (1.26-3.33)	0.007
LPL	rs328	Dominant	C/C, C/G + G/G	1.00 (reference), 1.34 (1.10-1.64)	0.004
CETP	rs708272	Codominant	A/A, A/G, G/G	1.00 (reference), 0.88 (0.70-1.11), 0.62 (0.43-0.89)	0.011
CETP	rs708272	Dominant	A/A, A/G + G/G	1.00 (reference), 0.82 (0.66-1.01)	0.064
CETP	rs708272	Recessive	A/A + A/G, G/G	1.00 (reference), 0.64 (0.46-0.89)	0.008

OR: Odds ratio; 95%CI: 95% confidence interval.